Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus vaginal progestogens in women with recurrent miscarriage
IRCT20230117057148N1Phase 4Completed
- Sponsor
- Lady Reading Hospital
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of progesterone and dydrogesterone in recurrent miscarriage (RPL) (2 arms), sponsored by Lady Reading Hospital. Primary endpoint: Miscarriage. Started Apr 2020; status: completed.
02
Drugs
progesteronedydrogesterone
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on IRCT20230117057148N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230117057148N1.